Two Wall Street firms initiated coverage on Coinshares and Bioage Labs with Outperform and Buy ratings, setting price targets of $9 and $40 respectively.
Keefe, Bruyette & Woods analyst Alex Bond initiated coverage on Coinshares PLC (NASDAQ:CSHR) with an Outperform rating and a $9 price target. Shares closed at $6.11 on Tuesday, reflecting potential upside of over 47% from current levels.
BTIG analyst Thomas Shrader initiated coverage on Bioage Labs Inc (NASDAQ:BIOA) with a Buy rating and a $40 price target. The stock closed at $18.19 on Tuesday, indicating a potential gain of more than 120% based on the new target.
The initiations highlight growing analyst interest in both companies, with price targets significantly above current trading levels. No prior consensus estimates were available for comparison.